Navigation Links
New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
Date:9/19/2007

postmenopausal women with osteoporosis, Boniva increases bone mineral density and reduces the incidence of vertebral fractures. Boniva also may be considered for postmenopausal women who are at risk of developing osteoporosis and for whom the desired clinical outcome is to maintain bone mass and reduce the risk of vertebral fracture.

Once-monthly Boniva is a small, film-coated, easy-to-swallow tablet dosed at 150 mg. Patients should take Boniva with plain water on an empty stomach upon rising in the morning. They should remain upright and avoid food, drink and other medications for at least 60 minutes.

Patients who take Boniva are eligible to sign up for MyBONIVA, a program designed to help enhance compliance (taking therapy as directed) and persistence with this unique once-monthly regimen. For more information on this program call 1-800-4BONIVA or visit http://www.MyBoniva.com.

Important Safety Information

Boniva is contraindicated in patients unable to stand or sit upright for at least 60 minutes, with uncorrected hypocalcemia, or with known hypersensitivity to any component of Boniva. Boniva, like other bisphosphonates administered orally, may cause upper gastrointestinal disorders such as dysphagia, esophagitis, and esophageal or gastric ulcer. Boniva is not recommended in patients with severe renal impairment. Adequate intake of calcium and Vitamin D is important in all patients.

Rarely, patients have reported severe bone, joint and/or muscle pain after taking bisphosphonate therapy for osteoporosis. Additionally, osteonecrosis of the jaw has been reported in patients treated with bisphosphonates; most cases have been in cancer patients undergoing dental procedures.

The most commonly reported adverse events with once-monthly Boniva regardless of causality were abdominal pain (Boniva 150 mg 7.8% vs. Boniva 2.5 mg 5.3%), hypertension (6.3% vs. 7.3%), dyspepsia (5.6% vs. 7.1%
'/>"/>

SOURCE Roche and GSK
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... shares have been approved for listing and trading on the ... ESSA will begin trading on NASDAQ on July 9, 2015.  ... Exchange under the symbol "EPI". As a result ... each of the Company,s outstanding special warrants issued on January ...
(Date:7/2/2015)... , July 2, 2015  Before you head outdoors ... so you can stay safe and healthy. Take steps to ... Infographic http://nyackhospital.org/summersafety Protect Your Skin From ... the sun can increase your risk of skin cancer. To ... as much as possible, especially during midday hours. Wear a ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) has ... Analog, Application, End-User & by Region - Global Trends & ... This market is projected to reach about $2.5 Million by ... and rising opportunities in countries such as India ... , and Brazil . In 2013, ...
Breaking Medicine Technology:ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3
... MINNEAPOLIS, May 25, 2011 Uroplasty, Inc. (NASDAQ: ... markets innovative proprietary products to treat voiding dysfunctions, today reported ... ended March 31, 2011. Global sales grew 35% ... 31, 2011, compared with $3.0 million in the fourth fiscal ...
... Sutter Health joins more than a dozen nationally-recognized ... – a project that will share comparative data to ... health care costs across the U.S. ... demonstrable improvements in how we deliver health care to ...
Cached Medicine Technology:Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 2Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 3Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 4Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 5Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 6Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 7Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 8Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 9Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 10Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 11Sutter Health Joins Health Systems Nationwide to Share and Compare Data on Quality, Outcomes and Cost 2Sutter Health Joins Health Systems Nationwide to Share and Compare Data on Quality, Outcomes and Cost 3
(Date:7/2/2015)... ... 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening ... store located in the Lone Star State. The premium frozen yogurt chain was listed ... The store, which opened July 1 at Duke’s Travel Plaza, is located at:, 30176 ...
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker Parking ... the University of Minnesota, they knew it would save the university energy and ... award-winning choice: the total energy savings after installation was an impressive 89 percent, ...
(Date:7/2/2015)... ... 2015 , ... In 2012, Patrick Achebe realized that the gift of poetry was fully in ... write his first poem, and three years later he was publishing an entire book of ... with the world. "I have always believed that the best way to lift yourself up, ...
(Date:7/2/2015)... ... July 02, 2015 , ... Get ... the SIGVARIS PERFORMANCE SOCKS. Since the socks were first introduced, they have rapidly ... significant popularity has inspired four new, fun shades including: blue, lime, pink and ...
(Date:7/2/2015)... ... July 02, 2015 , ... The ZAC Foundation, a national leader in water ... lessons on how to stay water safe with the help of a young polar ... The ZAC Foundation co-founders, follows Zeke’s water safety journey. Zeke, who is afraid ...
Breaking Medicine News(10 mins):Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3
... Plans, MIAMI, Feb. 11 AvMed Health Plans, ... employers, announces the,addition of competitive new plans to its ... existing plans. These plans offer low,co-payments for routine office ... co-pays for prescription drugs. AvMed also introduced new,pairing choices, ...
... have a low incidence of malignancy, so women with ... surgical biopsy, according to a new study by a ... in Jerusalem. , A fibroadenoma is a benign growth ... They are not usually associated with breast cancer, and ...
... in just 6 Hours, FORT LEE, N.J., Feb. ... new flea treatment. Vectra(TM) for Cats & Kittens and,Vectra(TM) ... delivers rapid, effective and more complete relief for cats ... ), The new Vectra product: -- Kills ...
... and BEIJING, Feb. 11 /Xinhua-PRNewswire-FirstCall/ -- China,Holdings, ... a global,diversified assets holdings company, and its ... energy, renewable,energy, resources, finance, real estate, utilities ... Company,s CEO, Julianna Lu, by Wall,Street Reporter, ...
... to ... Meet Burgeoning Demand, MALVERN, Pa., Feb. 11 ... Imaging of Ringgold,Ga., has become the first facility in the United ... (http://www.usa.siemens.com/healthcare ) -- the MAGNETOM(R) ESSENZA. The most,affordable all new 1.5 ...
... Tracy Bahl Joins Board of Directors as Chairman, ... (Emdeon) announced today that General Atlantic LLC (General,Atlantic) ... the purchase,of all remaining interests in Emdeon held ... 52% interest in Emdeon from HLTH in,November 2006., ...
Cached Medicine News:Health News:AvMed's New 2008 Plans Priced 50% Less 2Health News:Study finds patients with complex fibroadenomas can avoid surgery 2Health News:Summit VetPharm Introduces New Feline Topicals Vectra(TM) for Cats & Kittens and Vectra(TM) for Cats 2Health News:Summit VetPharm Introduces New Feline Topicals Vectra(TM) for Cats & Kittens and Vectra(TM) for Cats 3Health News:Wall Street Reporter Spotlights China Holdings Inc. and Asia's Hunger for Alternative Energy 2Health News:Wall Street Reporter Spotlights China Holdings Inc. and Asia's Hunger for Alternative Energy 3Health News:Wall Street Reporter Spotlights China Holdings Inc. and Asia's Hunger for Alternative Energy 4Health News:Wall Street Reporter Spotlights China Holdings Inc. and Asia's Hunger for Alternative Energy 5Health News:Siemens Healthcare Kicks Off New Era of Expanded Access to High-Field MRI with First Install of Affordable MAGNETOM ESSENZA 2Health News:Siemens Healthcare Kicks Off New Era of Expanded Access to High-Field MRI with First Install of Affordable MAGNETOM ESSENZA 3Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 2Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 3Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 4
For the measurement of vaginal pH as part of a self examination programme to help reduce the risk of pre-term birth...
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: